EXEL vs GILD
Exelixis, Inc. and Gilead Sciences, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | EXEL | GILD |
|---|---|---|
| Revenue | $2.3B | $29.4B |
| Net income | $782.6M | $8.5B |
| Gross margin | 96.4% | 78.8% |
| Net margin | 33.7% | 28.9% |
| Return on equity | 35.5% | 40.5% |
| Diluted EPS | $2.78 | $6.78 |
| Dividend / share | · | $3.16 |
| Payout ratio | · | 47.0% |
| Free cash flow | $875.8M | $9.5B |
| Equity | $2.2B | $22.7B |
| Net debt / equity | · | 0.77× |
| Current ratio | 3.56× | 1.55× |
| Revenue CAGR 5y | 18.6% | 3.6% |
| Profit CAGR 5y | 47.6% | 133.3% |
GILD bills 12.7× the revenue of EXEL, and EXEL keeps more of each dollar of revenue as profit (33.7% against 28.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | EXEL | GILD |
|---|---|---|
| FY2025 | $2.3B | $29.4B |
| FY2024 | $2.2B | $28.8B |
| FY2023 | $1.8B | $27.1B |
| FY2022 | $1.6B | $27.3B |
| FY2021 | $1.4B | $27.3B |
| FY2020 | $987.5M | $24.7B |
| FY2019 | $967.8M | $22.4B |
| FY2018 | $853.8M | $22.1B |
| FY2017 | $452.5M | $26.1B |
| FY2016 | $191.5M | $30.4B |
Bottom line
| Fiscal year | EXEL | GILD |
|---|---|---|
| FY2025 | $782.6M | $8.5B |
| FY2024 | $521.3M | $480.0M |
| FY2023 | $207.8M | $5.7B |
| FY2022 | $182.3M | $4.6B |
| FY2021 | $231.1M | $6.2B |
| FY2020 | $111.8M | $123.0M |
| FY2019 | $321.0M | $5.4B |
| FY2018 | $690.1M | $5.5B |
| FY2017 | $154.2M | $4.6B |
| FY2016 | $-70.2M | $13.5B |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$27,122,874,000 | GILD |
| FY2024 | −$26,585,299,000 | GILD |
| FY2023 | −$25,285,792,000 | GILD |
| FY2022 | −$25,669,938,000 | GILD |
| FY2021 | −$25,870,030,000 | GILD |
| FY2020 | −$23,701,462,000 | GILD |
| FY2019 | −$21,481,225,000 | GILD |
| FY2018 | −$21,273,174,000 | GILD |
| FY2017 | −$25,654,523,000 | GILD |
| FY2016 | −$30,198,546,000 | GILD |
| FY2015 | −$32,601,828,000 | GILD |
| FY2014 | −$24,864,889,000 | GILD |
| FY2013 | −$11,170,662,000 | GILD |
| FY2012 | −$9,654,550,000 | GILD |
| FY2011 | −$8,095,749,000 | GILD |
| FY2010 | −$7,764,375,000 | GILD |
| FY2009 | −$6,859,624,000 | GILD |
GILD has reported the higher revenue in every one of these 17 fiscal years. The gap has widened since the earliest year compared.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +4.8 pp | EXEL |
| FY2024 | +22.4 pp | EXEL |
| FY2023 | −9.3 pp | GILD |
| FY2022 | −5.4 pp | GILD |
| FY2021 | −6.6 pp | GILD |
| FY2020 | +11.0 pp | EXEL |
| FY2019 | +9.3 pp | EXEL |
| FY2018 | +56.1 pp | EXEL |
| FY2017 | +16.3 pp | EXEL |
| FY2016 | −81.1 pp | GILD |
| FY2015 | −490.6 pp | GILD |
| FY2014 | −1089.0 pp | GILD |
| FY2013 | −787.4 pp | GILD |
| FY2012 | −332.8 pp | GILD |
| FY2011 | −7.1 pp | GILD |
| FY2010 | −86.2 pp | GILD |
| FY2009 | −126.5 pp | GILD |
The higher net margin has changed hands between EXEL and GILD over this period.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's net margin has been more volatile than GILD's over the 17 comparable fiscal years — 308.5 percentage points of standard deviation against 14.2.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between EXEL and GILD over these 17 fiscal years — EXEL led in 6 and GILD in 11.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's return on equity has been more volatile than GILD's over the 11 comparable fiscal years — 74.1 percentage points of standard deviation against 11.5.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between EXEL and GILD over these 11 fiscal years — EXEL led in 4 and GILD in 7.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.